Status:
TERMINATED
rTMS Pilot for Anxiety
Lead Sponsor:
University of Pennsylvania
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and tolerability of 1 Hz parietal stimulation in anxiety. Our approach will be to administer 1 week of open-label accelerated 1 Hz parietal rTMS (5 ...
Detailed Description
Aims 1 and 2 of this project will be tested using a within-subjects design where anxiety patients will receive a 5-day course of accelerated 1 Hz rTMS (8x session x 600 pulses/session) to the right IP...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Meet the DSM-V criteria for an anxiety disorder (i.e. generalized anxiety disorder, social anxiety disorder, panic disorder, etc.)
- Subjects must be 18-50 years old
- Able to give their consent
- Right-handed
- Exclusion Criteria
- Non-english speaking
- Any significant medical or neurological problems
- Current or past (non-anxiety) Axis I psychiatric disorder(s), active or history of active suicidal ideation
- Alcohol/drug problems in the past year or lifetime alcohol or drug dependence
- Any medical condition that increases risk for TMS
- History of seizure
- History of epilepsy
- Increased risk of seizure for any reason
- Pregnancy, or positive pregnancy test
- Hearing loss
Exclusion
Key Trial Info
Start Date :
May 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05306977
Start Date
May 19 2022
End Date
August 1 2022
Last Update
April 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104